CymaBay Therapeutics

7999 Gateway Blvd.
Suite 130
United States

Tel: 510-293-8800


Show jobs for this employer

About CymaBay Therapeutics

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPARδ agonist, currently in development for the treatment of patients with primary biliary cholangitis (PBC), an autoimmune liver disease, and with non-alcoholic steatohepatitis (NASH).

157 articles about CymaBay Therapeutics